Comparison of early diagnostic value between plasma microRNA-1 and cardiac troponin T in patients with acute myocardial infarction
10.3760/cma.j.issn.1671-0282.2013.11.010
- VernacularTitle:血浆microRNA-1与肌钙蛋白T在急性心肌梗死早期诊断中的比较
- Author:
Liming LI
;
Wenbo CAI
;
Qin YE
;
Jianmin LIU
;
Xin LI
;
Xiaoxing LIAO
- Publication Type:Journal Article
- Keywords:
MicroRNA-1;
High sensitive cardiac troponin T;
Acute myocardial infarction;
Biomarker;
Early diagnosis;
Specificity;
Sensitivity
- From:
Chinese Journal of Emergency Medicine
2013;22(11):1247-1251
- CountryChina
- Language:Chinese
-
Abstract:
Objective To detect the level of plasma microRNA-1 (miR-1) in acute myocardial infarction (AMI) and compare the diagnostic values of it with that of cardiac troponin T (cTnT).Methods During 2011-05 to 2012-05,there were fifty-six plasma samples taken from patients with AMI and twenty-eight plasma specimens got from non-AMI controls were analyzed.The expression of plasma miR-1 was measured by quantitative reverse transcription-polymerase chain reaction (qRT-PCR),and the level of plasma cTnT was measured by using electrochemiluminescence-based methods on the Elecsys 2010 Immunoassay Analyzer.Then,the SPSS 16.0 was used for the statistical analysis.Data were presented as means ± standard deviation unless otherwise described.The differences about clinical characteristics between AMI patients and controls were tested using Student' s t-test or Fisher' s exact test.The Mann-Whitney test was conducted to compare the expression of microRNAs between the AMI patients and controls.The comparison of microRNAs expression between different intervals of AMI patients was done using Wilcoxon signed rank test.The receiver operating characteristic (ROC) curve was established to discriminate AMI patients from controls.Results The expression of plasma miR-1 was significantly increased in AMI patients (P < 0.01) compared with healthy controls.The contents of the plasma miR-1 in AMI patients fell down nearly to the normal level at 14 days (P > 0.05).There was no relevance between the expression of plasma miR-1 and the clinical characteristics of the study population (P > 0.05).Moreover,ROC curve analyses demonstrated that miR-1 had the specificity and sensitivity for the diagnosis of early AMI,but was not superior to cTnT.Conclusions Our results showed that plasma miR-1 had the capacity in early diagnosis of early AMI,and can be biomarker for AMI,however,miR-1 is not superior to cTnT for the diagnosis of AMI.